Position in JNJ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$901,339
+$33,822 QoQ
Shares Held
3,549
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
#3,116
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Roble, Belko & Company, Inc holds $3,192,754 across 12 Drug Manufacturers - General names. JNJ ranks #2 (28.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
5,506 | $1,385,529 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
3,549 | $901,339 | |
| 3 | LLY |
ELI LILLY & Co
|
416 | $498,962 | |
| 4 | PFE |
Pfizer Inc
|
8,245 | $198,539 | |
| 5 | MRK |
Merck & Co., Inc.
|
478 | $61,423 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
919 | $52,952 | |
| 7 | GSK |
GSK plc
|
685 | $35,907 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
218 | $27,542 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $901,339 | 3,549 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $867,517 | 3,549 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $734,465 | 3,549 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $658,055 | 3,549 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $410,897 | 2,690 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $451,084 | 2,720 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $500,819 | 3,463 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $524,750 | 3,238 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $472,681 | 3,234 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $511,586 | 3,234 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $506,897 | 3,234 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $258,856 | 1,662 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $284,363 | 1,718 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $266,290 | 1,718 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $308,784 | 1,748 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $217,268 | 1,330 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $236,088 | 1,330 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $253,438 | 1,430 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $278,844 | 1,630 | Shares | Sole | 2022-02-07 | |
| 2021-06-30 | $252,052 | 1,530 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $251,455 | 1,530 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $114,887 | 730 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $108,682 | 730 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $388,420 | 2,762 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $334,906 | 2,554 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||